The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksProvexis Share News (PXS)

Share Price Information for Provexis (PXS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.60
Bid: 0.55
Ask: 0.65
Change: 0.015 (2.56%)
Spread: 0.10 (18.182%)
Open: 0.585
High: 0.00
Low: 0.00
Prev. Close: 0.585
PXS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

EARNINGS SUMMARY: Provexis, Thruvision loss narrows; Unigel revenue up

Fri, 30th Sep 2022 21:11

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Friday and not separately reported by Alliance News:

----------

Kropz PLC - African phosphate developer - Pretax loss in the first half 2022 widens to USD60.9 million from USD7.4 million a year before. Can be put down to a USD44.7 million loss on the disposal of a subsidiary.

----------

Provexis PLC - Reading, England-based producer of heart-health functional food ingredient Fruitflow - Pretax loss in the first year to March 31 narrows to GBP299,132 from GBP361,803 the year before. Revenue falls 16% to GBP426,168 from GBP505,330. Explains the decrease in revenue with a fall from income received from its alliance agreement with DSM. Expects that the new gut microbiome patent application will have a strongly beneficial effect on current and future commercial prospects.

----------

Valereum PLC - Gibraltar-based blockchain technology - Pretax loss in the six months to June 30 widens to GBP1.0 million from GBP501,478 a year before, as administrative expenses jump to GBP1.0 million from GBP519,532. Records no revenue, slipping from GBP11,210. "We remain focused on establishing the Gibraltar Stock Exchange not only as one of the world's first fully regulated exchanges crossing the digital divide, but also linking into markets not touched by other European exchanges," Chair Richard Poulden comments.

----------

Rurelec PLC - London-based power producer with operations in Latin America - Swings to a pretax profit of GBP697,000 in the first half of 2022 from a loss of GBP875,000 a year before. Attributes this to a foreign exchange gain of GBP1.2 million. "The board continues to pursue measures to unlock the inherit value of the company through selling or developing assets and managing cash receipts from the power generation plant in Argentina. We are conscious that the economic situation in Argentina remains challenging and we continue to monitor the impact on our operating asset there," Executive Director Andy Coveney says.

----------

Stranger Holdings PLC - London-based investment company intending to acquire a target company, business or asset in the industrial or service sector - Pretax loss for the year to March 31 widens to GBP602,000 from GBP432,000 the year before. Administrative expenses jump to GBP457,000 versus GBP344,000.

----------

Unigel Group PLC - Eastbourne, East Sussex-based manufacturer of thixotropic gels for the fibre optic cable industry - Expects revenue of GBP17.9 million for the first half of 2022, up 87% year-on-year. Anticipates a pretax profit of GBP940,000, up 94% on a year ago. "The directors are pleased with the growth achieved in the first half of 2022 which arose from a combination of higher selling prices, new product introduction and new customer acquisition. Management continue to optimise the manufacturing capability of the group and continue to improve its product range through its in-house research and development team," the company states.

----------

Hawkwing PLC - London-based cash shell - Pretax loss for the first half of 2022 widens to GBP547,000 from GBP190,000 a year before. Records finance costs of GBP938,000.

----------

Xeros Technology Group PLC - Rotherham, England-based environmental technology firm - In the six months to June 30, pretax loss widens to GBP4.2 million from GBP3.4 million. Administrative expenses jump to GBP4.2 million versus GBP3.6 million. Revenue falls to GBP40,000 from GBP341,000. Blame this on licensing revenue, which fell 92%.

----------

Kendrick Resources PLC - London-based exploration company - Pretax loss in the first half of 2022 widens to GBP184,700 from GBP169,362 a year before. Operating expenses jump to GBP173,828 versus GBP153,408. Records no revenue, unchanged from a year before. Plans to build a long-term energy metals business in Scandinavia to deliver energy metals to Europe to help enable its renewable energy transformation

----------

Thruvision Group PLC - Abingdon, England-based people-screening technology - For the year which ends March 31, pretax loss narrows to GBP1.9 million from GBP2.8 million a year before. Revenue rises 25% to GBP8.4 million from GBP6.7 million. Credits this to a strong performance, driven by significant growth in Profit Protection. Believes it is well positioned to deliver good growth.

----------

By Abby Amoakuh; abbyamoakuh@alliancenews.com

Copyright 2022 Alliance News Limited. All Rights Reserved.

More News
3 Dec 2009 08:49

Small caps round-up: Landore Resources, TXO, Aortech...

Shares in Landore Resources jumped after the Canadian miner said it made a 'significant gold discovery' in its Junior Lake property in the province of Ontario. Shares in Texas-focused oil and gas firm TXO slumped after it said oil production in the six months to September 30 fell to 13,221 barrels

Read more
3 Nov 2009 12:16

Small cap round-up: Provexis, Puricore, Sirius, Sopheon, Spiritel

Food technology group Provexis says it has been told that the European Commission review into the health claim wording for its Fruitflow anti-thrombatic technology for use on consumer products is now in "an advanced stage". Puricore's third quarter sales rose 25% to $10.8m, with the nine month tot

Read more
11 Aug 2009 09:30

Provexis surges on Crohn's disease trial

Provexis, the life-science business, has begun a clinical trial for its NSP#3G plantain medical food for Crohn's disease patients. "With the trial now starting and combined with recently obtained healthy human data, the Company will now commence seeking to identify potential global license or co-de

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.